A Randomized Controlled Trial Comparing Two Doses of Caffeine for Apnoea in Prematurity

Caffeine is the most commonly used methyl xanthine for the prevention of apnoea in prematurity, but the ideal dose was uncertain, until now. This study compared two doses of caffeine for the prevention of apnoea in prematurity. A clinical trial was conducted on 78 preterm infants

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of environmental research and public health 2021-04, Vol.18 (9), p.4509, Article 4509
Hauptverfasser:	Mohd Kori, Anis Munirah, Van Rostenberghe, Hans, Ibrahim, Nor Rosidah, Yaacob, Najib Majdi, Nasir, Ariffin
Format:	Artikel
Sprache:	eng
Schlagworte:	Apnea Apnea - drug therapy Apnea - prevention & control Caffeine Caffeine - therapeutic use Cardiac arrhythmia Clinical trials Data collection Enteral nutrition Environmental Sciences Environmental Sciences & Ecology Gestational age Hospitals Humans Hypertension Infant Infant, Newborn Infant, Premature Infant, Premature, Diseases Intubation Life Sciences & Biomedicine Maintenance Meta-analysis Neonates Newborn babies Oxygen saturation Prevention Public, Environmental & Occupational Health Science & Technology Statistical analysis Urine Ventilators
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Caffeine is the most commonly used methyl xanthine for the prevention of apnoea in prematurity, but the ideal dose was uncertain, until now. This study compared two doses of caffeine for the prevention of apnoea in prematurity. A clinical trial was conducted on 78 preterm infants
ISSN:	1660-4601 1661-7827 1660-4601
DOI:	10.3390/ijerph18094509